期刊文献+

血清25(OH)维生素D与非酒精性脂肪性肝病肝纤维化的相关性研究 被引量:1

Correlation between serum 25(OH) vitamin D and liver fibrosis in nonalcoholic fatty liver disease
原文传递
导出
摘要 目的探讨血清25(OH)维生素D(25(OH)D)与非酒精性脂肪性肝病患者肝纤维化的关系。方法本实验集中选取同一地区秋季人群为研究对象,时间为2017年8~10月非酒精性脂肪性肝病者120例,根据肝纤维化评分(NFS)分为<-1.455亚组(可排除肝纤维化亚组),-1.455~0.676亚组(不确定亚组),>0.676亚组(肝纤维化亚组);选择同期体检的年龄、性别、地域相匹配的健康人群50例为对照组,应用ELISA法检测血清25(OH)D、CK18及YKL40水平。使用SPSS 19.0软件包对数据进行分析,肝纤维化指标和血清25(OH)D含量用(x^-±s)表示,两两比较采用t检验,多组间比较采用方差分析及Spearman相关分析。P<0.05表示差异有统计学意义。结果NFS>0.676组随着血清肝纤维化指标CK18、YKL40的升高,血清25(OH)D含量减低,呈负相关关系(P<0.05)。其他各组与血清25(OH)D含量未发现相关关系(P>0.05)。结论非酒精性脂肪性肝炎有肝纤维化趋势,血清25(OH)D与肝纤维化的进展密切相关。 Objective To investigate the relationship between serum 25(OH)vitamin D and liver fibrosis in patients with nonalcoholic fatty liver disease.Methods The experiment was focused on the autumn population in the same area.From August to October 2017,120 patients with nonalcoholic fatty liver disease were divided into<-1.455 subgroup according to nonalcoholic fatty liver fibrosis score(NFS).Excluding the liver fibrosis subgroup),-1.75-0.676 subgroup(unsure subgroup),>0.676 subgroup(liver fibrosis subgroup),50 healthy people with age,gender,and geographical matching were matched for the same physical examination In the control group,serum 25(OH)vitamin D,CK18 and YKL40 levels were measured by ELISA.SPSS 19.0 statistical software was used for data analysis.Liver fibrosis indexes and serum 25(OH)vitamin D were showed as(±s),compared with independent t test.Multiple date sets were compared with Variance and Spearman correlation analysis,P<0.05 indicated the difference was statistically significant.Results Serum 25(OH)vitamin D content decreased with the increase of serum liver fibrosis markers CK18 and YKL40 in NFS>0.676 group(P<0.05).There was no correlation between CK18,YKL40 and serum 25(OH)vitamin D in normal group,NFS<-1.455 group and-1.455≤NFS≤0.676 group(P>0.05).Conclusions Nonalcoholic steatohepatitis has a trend of liver fibrosis,and serum 25(OH)vitamin D is closely related to the progression of liver fibrosis.
作者 付丽坤 崔红梅 邹春燕 李莉 李京龙 谢长顺 南月敏 盛丽娜 Fu Likun;Cui Hongmei;Zou Chunyan;Li Li;Li Jinglong;Xie Changshun;Nan Yuemin;Sheng Lina(Department of Gastroenterology,the First Hospital of Qinhuangdao,Qinhuangdao 066000,China;Department of Traditional and Western Medical Hepatology,Third Hospital of Hebei Medical University,Shijiazhuang 050051)
出处 《中华普外科手术学杂志(电子版)》 2019年第6期603-605,共3页 Chinese Journal of Operative Procedures of General Surgery(Electronic Edition)
基金 秦皇岛市科学技术局科研项目(201703A044) 中国肝炎防治基金会天晴课题(TQGB20170122)~~
关键词 肝炎 肝硬化 脂肪肝 25-羟维生素D2 Hepatitis Liver cirrhosis Fatty liver 25-Hydroxyvitamin D2
  • 相关文献

参考文献4

二级参考文献33

  • 1中华医学会肝病学分会脂肪肝和酒精性肝病学组.酒精性肝病诊疗指南[J].中国肝脏病杂志(电子版),2010,2(4):49-53. 被引量:384
  • 2Feldstein AE, Wieckowska A, Lopez AR, Liu YC, Zein NN, McCullough AJ. Cytokeratin-18 fragment levels as noninvasive biomarkers for nonalcoholic steatohepatitis: a multicenter validation study. Hepatology 2009; 50:1072-1078 [PMID: 19585618 DOI: 10.1002/hep.23050].
  • 3Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, Feldstein AE. In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 2006; 44:27-33 [PMID: 16799979 DOh 10.1002/hep.21223].
  • 4Feldstein AE, Alkhouri N, De Vito R, Alisi A, Lopez R, Nobili V. Serum cytokeratin-18 fragment levels are useful biomarkers for nonalcoholic steatohepatitis in children. Am J Gastroenterol 2013; 108:1526-1531 [PMID: 23752877 DOI: 10.1038/ajg.2013.168].
  • 5Aida Y, Abe H, Tomita Y, Nagano T, Seki N, Sugita T, Itagaki M, Ishiguro H, Sutoh S, Aizawa Y. Serum cytokeratin 18 fragment level as a noninvasive biomarker for non-alcoholic fatty liver disease. Int J Clin Exp Med 2014; 7:4191-4198 [PMID: 25550930].
  • 6Luedde T, Kaplowitz N, Schwabe RF. Cell death and cell death responses in liver disease: mechanisms and clinical relevance. Gastroenterology 2014; 147:765-783.e4 [PMID: 25046161 DOI: 10.1053/j.gastro.2014.07.018].
  • 7Bantel H, Ltigering A, Heidemann J, Volkmann X, Poremba C, Strassburg CP, Manns MP, Schulze-Osthoff K. Detection of apoptotic caspase activation in sera from patients with chronic HCV infection is associated with fibrotic liver injury. Hepatology 2004; 40:1078-1087 [PMID: 15486927 DOI: 10.1002/hep.20411].
  • 8中华医学会内分泌分会肝病与代谢学组(筹).中华医学会内分泌分会菲酒精性脂肪性肝病与相关代谢紊乱诊疗共识.中华内分泌代谢杂志2010;26:531-533.
  • 9裴强,王晓素,王宪波.非酒精性脂肪性肝炎发病机制的研究进展[J].临床肝胆病杂志,2008,24(4):304-306. 被引量:31
  • 10You-Xiang Zhang,Wen-Juan Wu,Yun-Zhi Zhang,Yan-Ling Feng,Xin-Xi Zhou,Qi Pan.Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B[J].World Journal of Gastroenterology,2008,14(46):7117-7121. 被引量:14

共引文献42

同被引文献7

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部